Ashlyn Elizabeth Whitlock, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mesenchymal Stem Cell Transplantation | 12 | 2024 | 499 | 3.850 |
Why?
|
| Placenta | 10 | 2024 | 1709 | 1.770 |
Why?
|
| Mesenchymal Stem Cells | 7 | 2024 | 1642 | 1.540 |
Why?
|
| Amniotic Fluid | 11 | 2024 | 378 | 1.440 |
Why?
|
| Fetal Growth Retardation | 5 | 2024 | 580 | 1.220 |
Why?
|
| Rodentia | 2 | 2023 | 262 | 0.940 |
Why?
|
| Rectal Prolapse | 1 | 2024 | 33 | 0.900 |
Why?
|
| Anemia, Hemolytic | 1 | 2023 | 162 | 0.780 |
Why?
|
| Fecal Incontinence | 1 | 2024 | 241 | 0.750 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2024 | 8181 | 0.710 |
Why?
|
| Uterus | 1 | 2024 | 649 | 0.710 |
Why?
|
| Gastrointestinal Agents | 1 | 2024 | 510 | 0.650 |
Why?
|
| Fetal Diseases | 1 | 2023 | 913 | 0.580 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 2201 | 0.490 |
Why?
|
| Rats, Inbred Lew | 4 | 2023 | 1157 | 0.450 |
Why?
|
| Immunotherapy | 3 | 2023 | 4652 | 0.410 |
Why?
|
| Pregnancy | 14 | 2024 | 29876 | 0.400 |
Why?
|
| Crohn Disease | 1 | 2024 | 2279 | 0.380 |
Why?
|
| Rats | 9 | 2024 | 23741 | 0.360 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 1578 | 0.360 |
Why?
|
| Bariatric Surgery | 3 | 2018 | 992 | 0.230 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2023 | 104 | 0.210 |
Why?
|
| Fetal Weight | 1 | 2022 | 87 | 0.200 |
Why?
|
| Animals | 15 | 2024 | 168467 | 0.200 |
Why?
|
| Fetal Heart | 1 | 2023 | 281 | 0.190 |
Why?
|
| Liver Failure | 1 | 2023 | 250 | 0.180 |
Why?
|
| Altitude | 1 | 2021 | 163 | 0.180 |
Why?
|
| Intestinal Neoplasms | 1 | 2023 | 312 | 0.180 |
Why?
|
| Immunoglobulin G | 2 | 2023 | 4544 | 0.180 |
Why?
|
| Cholestasis | 1 | 2023 | 378 | 0.170 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 978 | 0.170 |
Why?
|
| Short Bowel Syndrome | 1 | 2023 | 353 | 0.160 |
Why?
|
| Constipation | 1 | 2024 | 563 | 0.160 |
Why?
|
| Female | 20 | 2024 | 392686 | 0.160 |
Why?
|
| Intestinal Diseases | 1 | 2023 | 504 | 0.160 |
Why?
|
| Personnel Loyalty | 1 | 2017 | 11 | 0.150 |
Why?
|
| Obesity, Morbid | 2 | 2018 | 1277 | 0.150 |
Why?
|
| Respiratory Function Tests | 1 | 2021 | 1682 | 0.140 |
Why?
|
| Interferon-gamma | 1 | 2024 | 3162 | 0.130 |
Why?
|
| Vena Cava Filters | 1 | 2018 | 261 | 0.130 |
Why?
|
| Fetus | 1 | 2023 | 1863 | 0.130 |
Why?
|
| Liver Diseases | 1 | 2023 | 1298 | 0.120 |
Why?
|
| Kinetics | 1 | 2022 | 6374 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 1809 | 0.110 |
Why?
|
| Humans | 18 | 2024 | 761572 | 0.110 |
Why?
|
| Acute Disease | 1 | 2024 | 7237 | 0.110 |
Why?
|
| Triage | 1 | 2020 | 986 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 21017 | 0.110 |
Why?
|
| Inflammation | 2 | 2023 | 10773 | 0.110 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 954 | 0.100 |
Why?
|
| Mastectomy | 1 | 2020 | 1822 | 0.100 |
Why?
|
| Community Health Services | 1 | 2017 | 656 | 0.100 |
Why?
|
| Luciferases | 2 | 2023 | 714 | 0.100 |
Why?
|
| Breast | 1 | 2020 | 1967 | 0.100 |
Why?
|
| Bone Marrow | 1 | 2021 | 2911 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 4352 | 0.090 |
Why?
|
| Laparoscopy | 2 | 2018 | 2036 | 0.090 |
Why?
|
| Mental Health | 1 | 2024 | 3250 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2024 | 15633 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 18253 | 0.070 |
Why?
|
| Lung | 2 | 2023 | 10002 | 0.070 |
Why?
|
| Social Support | 1 | 2017 | 2171 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2024 | 64684 | 0.070 |
Why?
|
| Quality Improvement | 2 | 2018 | 3801 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2024 | 80646 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 2567 | 0.060 |
Why?
|
| Pandemics | 2 | 2020 | 8656 | 0.060 |
Why?
|
| Adult | 6 | 2024 | 221203 | 0.050 |
Why?
|
| Swine | 2 | 2023 | 5915 | 0.050 |
Why?
|
| Phenyl Ethers | 1 | 2022 | 62 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
| PPAR alpha | 1 | 2023 | 175 | 0.050 |
Why?
|
| Chorion | 1 | 2022 | 114 | 0.050 |
Why?
|
| Amnion | 1 | 2023 | 197 | 0.050 |
Why?
|
| Bilirubin | 1 | 2023 | 436 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 5440 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2023 | 484 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2023 | 3397 | 0.040 |
Why?
|
| Infant | 1 | 2021 | 36192 | 0.040 |
Why?
|
| Young Adult | 2 | 2024 | 59255 | 0.040 |
Why?
|
| Parenteral Nutrition | 1 | 2023 | 659 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2023 | 2677 | 0.040 |
Why?
|
| Middle Aged | 5 | 2024 | 220920 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2023 | 1206 | 0.030 |
Why?
|
| Risk Factors | 1 | 2024 | 74213 | 0.030 |
Why?
|
| Fibrosis | 1 | 2023 | 2049 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 27120 | 0.030 |
Why?
|
| Mice | 1 | 2022 | 81533 | 0.030 |
Why?
|
| Triglycerides | 1 | 2023 | 2461 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2023 | 1808 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2023 | 1398 | 0.030 |
Why?
|
| Intestines | 1 | 2023 | 1909 | 0.030 |
Why?
|
| Male | 5 | 2024 | 360842 | 0.030 |
Why?
|
| Uganda | 1 | 2017 | 1332 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2022 | 4160 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 169310 | 0.020 |
Why?
|
| Urban Population | 1 | 2018 | 2036 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2017 | 2495 | 0.020 |
Why?
|
| Patient Selection | 1 | 2020 | 4244 | 0.020 |
Why?
|
| Liver | 1 | 2023 | 7529 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 7827 | 0.010 |
Why?
|
| Logistic Models | 1 | 2018 | 13255 | 0.010 |
Why?
|
| Comorbidity | 1 | 2018 | 10508 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18398 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21355 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 41493 | 0.010 |
Why?
|
| United States | 1 | 2018 | 72335 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 88324 | 0.000 |
Why?
|